NorthRock Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,247
Closed -$556K 875
2025
Q3
$556K Buy
2,247
+957
+74% +$229K 0.01% 501
2025
Q2
$310K Buy
1,290
+231
+22% +$53.8K 0.01% 523
2025
Q1
$240K Sell
1,059
-58
-5% -$12.8K 0.01% 515
2024
Q4
$230K Sell
1,117
-471
-30% -$103K 0.01% 542
2024
Q3
$385K Buy
1,588
+27
+2% +$6.31K 0.01% 426
2024
Q2
$343K Buy
1,561
+233
+18% +$50.6K 0.01% 438
2024
Q1
$299K Buy
1,328
+3
+0.2% +$677 0.01% 483
2023
Q4
$291K Buy
1,325
+253
+24% +$53.5K 0.01% 461
2023
Q3
$235K Buy
+1,072
New +$243K 0.02% 290
2022
Q2
Sell
-909
Closed -$220K 347
2022
Q1
$220K Buy
+909
New +$211K 0.02% 304

Other funds holding STE

NorthRock Partners's STE Position: Q4 2025 in Review

NorthRock Partners sold out of Steris (STE) in Q4 2025, closing a stake of 2,247 shares — an estimated $556K sold.

NorthRock Partners first reported a position in STE in Q1 2022 and held it in 10 quarters. The position peaked at $556K in Q3 2025. 894 funds tracked by Wall St. Rank hold STE as of Q4 2025.

  • NorthRock Partners reported no remaining Steris position as of Q4 2025 after selling out during the quarter.
  • NorthRock Partners sold 2,247 Steris shares in Q4 2025, an estimated $556K.
  • NorthRock Partners first reported a position in Steris in Q1 2022 and held it in 10 quarters.
  • NorthRock Partners's Steris position peaked at $556K in Q3 2025.
  • 894 funds tracked by Wall St. Rank held Steris as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.